Winslow Evans & Crocker’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Winslow Evans & Crocker’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-54	Closed	-$6.05K	–	1265
2017 Q2	$6.05K	Hold	54	–	–	﹤0.01%	1026
2017 Q1	$6.3K	Hold	54	–	–	﹤0.01%	989
2016 Q4	$5.69K	Sell	54 -80	-60%	-$8.38K	﹤0.01%	1015
2016 Q3	$14.7K	Hold	134	–	–	﹤0.01%	810
2016 Q2	$19.4K	Buy	134 +1	+0.8%	+$142	0.01%	698
2016 Q1	$19.1K	Sell	133 -1	-0.7%	-$142	0.01%	716
2015 Q4	$20.6K	Hold	134	–	–	0.01%	740
2015 Q3	$19K	Hold	134	–	–	0.01%	736
2015 Q2	$19.1K	Hold	134	–	–	0.01%	774
2015 Q1	$18.8K	Hold	134	–	–	0.01%	746
2014 Q4	$19.7K	Hold	134	–	–	0.01%	731
2014 Q3	$20.5K	Sell	134 -26	-16%	-$3.92K	0.01%	734
2014 Q2	$22.4K	Hold	160	–	–	0.01%	650
2014 Q1	$17.8K	Buy	160 +54	+51%	+$5.88K	0.01%	702
2013 Q4	$10K	Buy	+106	New	+$9.19K	﹤0.01%	918

Other funds holding TARO

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Winslow Evans & Crocker's TARO Position: Q3 2017 in Review

Winslow Evans & Crocker sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2017, closing a stake of 54 shares — an estimated $6.05K sold.

Winslow Evans & Crocker first reported a position in TARO in Q4 2013 and held it in 15 quarters. The position peaked at $22.4K in Q2 2014. 133 funds tracked by Wall St. Rank hold TARO as of Q3 2017.

Winslow Evans & Crocker reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2017 after selling out during the quarter.
Winslow Evans & Crocker sold 54 Taro Pharmaceutical Industries Ltd. shares in Q3 2017, an estimated $6.05K.
Winslow Evans & Crocker first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2013 and held it in 15 quarters.
Winslow Evans & Crocker's Taro Pharmaceutical Industries Ltd. position peaked at $22.4K in Q2 2014.
133 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2017.

Based on Winslow Evans & Crocker's 13F filing for Q3 2017, filed 19 Oct 2017.